Table 1 Baseline clinical characteristics of participants; control & intervention

Parameters

Control Arm, n = 121

Intervention Arm, n = 123

p–values

Age (Yrs)

50.4 ± 7.7

50.3 ± 10.5

0.89

Age at diagnosis of DM(Yrs)

42.8 ± 7.9

44.2 ± 9.8

0.24

Duration of DM (Yrs)

7.6 ± 5.4

6.1 ± 5.3

0.029*

Haemoglobin (mg/dL)

13.2 4 ± 1.1

13.9 ± 1.1

0.69

Weight (Kg)

78.3 ± 14.4

77.5 ± 17.6

0.72

Waist (cm)

110 ± 16.5

109 ± 16.5

0.86

BMI (Kg/m ² )

30.6 ± 4.9

30.8 ± 6.4

0.79

Systolic BP (mmHg)

133 ± 15.4

145 ± 20.9

0.0001**

Diastolic BP (mmHg)

85 ± 10.4

94 ± 10.7

0.0001**

eABG (mg/dL)

261 ± 49.8

268 ± 50.2

0.25

HbA1c

10.7 ± 1.7

11.0 ± 1.7

0.25

Cholesterol (mg/dL)

231 ± 55.7

223 ± 51.3

0.26

Triglycerides(mg/dL)

191 ± 79.7

272 ± 112.1

0.0001**

HDL-C (mg/dL)

48 ± 12.5

49 ± 18.2

0.45

LDL-C (mg/dL)

145 ± 48.5

119 ± 50.3

0.0001**

VLDL-C (mg/dL)

38 ± 15.9

54 ± 22.4

0.0001**

Serum Creatinine (mg/dL)

1.0 ± 0.3

1.1 ± 0.4

0.007*

 None

2 (1.7%)

1 (0.8%)

 OHA

66 (54.5%)

72 (58.5%)

0.51

 OHA + Insulin

43 (35.5%)

45 (36.6%)

 Insulin

10 (8.3%)

5 (4.1%)